683 research outputs found
GSH_meta_supplementary_figures_20190320 – Supplemental material for Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis
No full textSupplemental material, GSH_meta_supplementary_figures_20190320 for Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis by Sakiko Tsugawa, Yoshihiro Noda, Ryosuke Tarumi, Yu Mimura, Kazunari Yoshida, Yusuke Iwata, Muhammad Elsalhy, Minori Kuromiya, Shin Kurose, Fumi Masuda, Shinji Morita, Kamiyu Ogyu, Eric Plitman, Masataka Wada, Takahiro Miyazaki, Ariel Graff-Guerrero, Masaru Mimura and Shinichiro Nakajima in Journal of Psychopharmacology</p
GSH_meta_supplementary_table_20190320 – Supplemental material for Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis
No full textSupplemental material, GSH_meta_supplementary_table_20190320 for Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis by Sakiko Tsugawa, Yoshihiro Noda, Ryosuke Tarumi, Yu Mimura, Kazunari Yoshida, Yusuke Iwata, Muhammad Elsalhy, Minori Kuromiya, Shin Kurose, Fumi Masuda, Shinji Morita, Kamiyu Ogyu, Eric Plitman, Masataka Wada, Takahiro Miyazaki, Ariel Graff-Guerrero, Masaru Mimura and Shinichiro Nakajima in Journal of Psychopharmacology</p
AUT822502_Lay_Abstract – Supplemental material for Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review
No full textSupplemental material, AUT822502_Lay_Abstract for Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review by Fumi Masuda, Shinichiro Nakajima, Takahiro Miyazaki, Ryosuke Tarumi, Kamiyu Ogyu, Masataka Wada, Sakiko Tsugawa, Paul E Croarkin, Masaru Mimura and Yoshihiro Noda in Autism</p
AUT822502_Supplemental_material – Supplemental material for Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review
No full textSupplemental material, AUT822502_Supplemental_material for Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review by Fumi Masuda, Shinichiro Nakajima, Takahiro Miyazaki, Ryosuke Tarumi, Kamiyu Ogyu, Masataka Wada, Sakiko Tsugawa, Paul E Croarkin, Masaru Mimura and Yoshihiro Noda in Autism</p
AUT827134_Lay_Abstract – Supplemental material for Job interview training targeting nonverbal communication using an android robot for individuals with autism spectrum disorder
No full textSupplemental material, AUT827134_Lay_Abstract for Job interview training targeting nonverbal communication using an android robot for individuals with autism spectrum disorder by Hirokazu Kumazaki, Taro Muramatsu, Yuichiro Yoshikawa, Blythe A Corbett, Yoshio Matsumoto, Haruhiro Higashida, Teruko Yuhi, Hiroshi Ishiguro, Masaru Mimura and Mitsuru Kikuchi in Autism</p
Supplemental Material - Late-Life High Blood Pressure and Enlarged Perivascular Spaces in the Putaminal Regions of Community-Dwelling Japanese Older Persons (JPSC-AD)
No full textSupplemental Material for Late-Life High Blood Pressure and Enlarged Perivascular Spaces in the Putaminal Regions of Community-Dwelling Japanese Older Persons (JPSC-AD) by Ayumi Tachibana, Jun-ichi Iga Yasuko Tatewaki, Benjamin Thyreau, Hongkun Chen, Tomoki Ozaki, Taku Yoshida, Yuta Yoshino, Hideaki Shimizu, Takaaki Mori, Yoshihiko Furuta, Mao Shibata, Tomoyuki Ohara, Jun Hata, Yasuyuki Taki, Shigeyuki Nakaji, Tetsuya Maeda, Kenjiro Ono, Masaru Mimura, Kenji Nakashima, Minoru Takebayashi, Toshiharu Ninomiya, and Shu-ichi Ueno for the JPSC-AD study group in Journal of Geriatric Psychiatry and Neurology</p
Comorbidity of Depression and Other Diseases Masaru MIMURA
No full textAbstract: This paper outlines the comorbidity of depression and other diseases that are frequently seen in the primary care of depression. Since the operational diagnostic criteria of the DSM-III-R (Diagnostic and Statistical Manual of Mental Disorders, revised 3rd edition) and the current DSM-IV (4th edition) were introduced to Japan from the U.S., Japanese psychiatrists have become active in assigning a single patient parallel or overlapping diagnoses of mental disorders. In patients with depression, the comorbidity of anxiety disorder (panic disorder, generalized anxiety disorder), obsessive-compulsive disorder, drug dependence, alcohol dependence, post-traumatic stress disorder, or personality disorder is an issue. When depression is comorbid with another mental disorder, both disorders are reported to be severer, more likely to be refractory, and more likely to be associated with a poor prognosis. Although the concept of comorbidity in the field of mental disorders is useful in understanding patients' symptoms and determining prognosis, it is also possible that the patient's pathological structure is too greatly simplified. The concept of comorbidity should be employed within the limits of its clinical usefulness, while maintaining full recognition of this possible simplification
Green tea consumption and cerebral white matter lesions in community-dwelling older adults without dementia
No full textPreKURA:1657On behalf of the Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD) study group:
Toshiharu Ninomiya, Mao Shibata, Takanori Honda, Jun Hata, Tomoyuki Ohara, Masato Akiyama, Shigeyuki Nakaji, Koichi Murashita, Tatsuya Mikami, Kaori Sawada, Shintaro Yokoyama, Tetsuya Maeda, Naoki Ishizuka, Hiroshi Akasaka, Yasuo Terayama, Hisashi Yonezawa, Junko Takahashi, Kenjiro Ono, Moeko Noguchi-Shinohara, Kazuo Iwasa, Sohshi Yuki-Nozaki, Masahito Yamada, Masaru Mimura, Shogyoku Bun, Hidehito Niimura, Ryo Shikimoto, Hisashi Kida, Kenji Nakashima, Yasuyo Fukada, Hisanori Kowa, Toshiya Nakano, Kenji Wada, Masafumi Kishi, Tomoki Ozaki, Ayumi Tachibana, Yuta Yoshino, Jun-ichi Iga, Shu-ichi Ueno, Minoru Takebayashi, Naoto Kajitani, Yusuke Miyagawa, Tomohisa Ishikawa, Seiji Yuki, Ryuji Fukuhara, Asuka Koyama, Mamoru Hashimoto, Manabu Ikeda, Yoshihiro Kokubo, Kazuhiro Uchida, Midori Esaki, Yasuyuki Taki, Yasuko Tatewaki, Benjamin Thyreau, Hisako Yoshida, Kaori Muto, Yusuke Inoue, Izen Ri, Yukihide Momozawa, Chikashi Terao, Michiaki Kubo & Yutaka Kiyoharajournal articl
Smartphone viewing distance and sleep: an experimental study utilizing motion capture technology
No full textMichitaka Yoshimura,1,* Momoko Kitazawa,1–3,* Yasuhiro Maeda,2 Masaru Mimura,4 Kazuo Tsubota,1 Taishiro Kishimoto,4,5 1Department of Ophthalmology, Keio University School of Medicine, Tokyo, 2RIKEN Center for Advanced Photonics, Wako, Saitama, 3Department of Nursing, Aino University Junior College, 4Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; 5Department of Psychiatry, Hofstra Northwell School of Medicine, NY, USA *These authors contributed equally to this work Abstract: There are studies reporting the negative impact of smartphone utilization on sleep. It is considered that reduction of melatonin secretion under the blue light exposure from smartphone displays is one of the causes. The viewing distance may cause sleep disturbance, because the viewing distance determines the screen illuminance and/or asthenopia. However, to date, there has been no study closely investigating the impact of viewing distance on sleep; therefore, we sought to determine the relationship between smartphone viewing distance and subjective sleep status. Twenty-three nursing students (mean age ± standard deviation of 19.7±3.1 years) participated in the study. Subjective sleep status was assessed using the Pittsburgh Sleep Quality Index, morningness–eveningness questionnaire, and the Epworth sleepiness scale. We used the distance between the head and the hand while holding a smartphone to measure the viewing distance while using smartphones in sitting and lying positions. The distance was calculated using the three-dimensional coordinates obtained by a noncontact motion-sensing device. The viewing distance of smartphones in the sitting position ranged from 13.3 to 32.9 cm among participants. In the lying position, it ranged from 9.9 to 21.3cm. The viewing distance was longer in the sitting position than in the lying position (mean ± standard deviation: 20.3±4.7 vs 16.4±2.7, respectively, P<0.01). We found that the short viewing distance in the lying position had a positive correlation to a poorer sleep state (R2=0.27, P<0.05), lower sleep efficiency (R2=0.35, P<0.05), and longer sleep latency (R2=0.38, P<0.05). Moreover, smartphone viewing distances in lying position correlated negatively with subjective sleep status. Therefore, when recommending ideal smartphone use in lying position, one should take into account the viewing distances. Keywords: smartphone, sleep, blue light, distanc
Exercise program improved subjective dry eye symptoms for office workers
No full textKokoro Sano,1 Motoko Kawashima,1 Sayuri Takechi,2 Masaru Mimura,2 Kazuo Tsubota1 1Department of Ophthalmology, 2Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan Introduction: We investigated the benefits of a cognitive behavior therapy-based exercise program to reduce the dry eye symptoms of office workers. Materials and methods: We recruited 11 office workers with dry eye symptoms, aged 31–64 years, who voluntarily participated in group health guidance at a manufacturing company. Participants learned about the role of physical activity and exercise in enhancing wellness and performed an exercise program at home 3 days per week for 10 weeks. We estimated the indexes of body composition, dry eye symptoms, and psychological distress using the Dry Eye-Related Quality of Life Score and the World Health Organization’s Subjective Well-Being Inventory questionnaires pre- and postintervention. Results: The 10-week exercise program and the questionnaires were completed by 48.1% (39 of 81) of the participants. Body composition did not change pre- and postintervention. However, the average of the Dry Eye-Related Quality of Life Score scores in participants with subjective dry eye significantly improved after the intervention. Moreover, the World Health Organization’s Subjective Well-Being Inventory positive well-being score tended to increase after the intervention. Conclusion: In this study, we showed that a 10-week exercise program improved subjective dry eye symptoms of healthy office workers. Our study suggests that a cognitive behavior therapy-based exercise program can play an important role in the treatment of patients with dry eye disease. Keywords: dry eye, exercise, office workers, cognitive behavioral therap
- …
